Assura plc ('Assura'), the UK's leading primary care property investor and developer, today announces that, following its recent equity raise, it has repaid £211 millionof long term debt held by Aviva Commercial Finance, with associated early repayment costs of £56 million. The weighted average interest rate on the loans redeemed was 5.43%. This repayment is in line with the debt reduction plan announced in our Prospectus dated 16 November 2017.
Following the repayment, gross debt will be £430 million and Assura will benefit from the resultant reduced weighted average cost of interest, as well as substantial capacity for further property investment.
Further details will be provided with the financial results for the year ended 31 March 2018, which are due to be released on 23 May 2018.
- Ends -
For more information, please contact:
Assura plc
Tel: 01925 420660
Jonathan Murphy
Jayne Cottam
Orla Ball
Edelman
Tel: 0203 047 2546
John Kiely
Mav Wynn
Rob Yates
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UKREIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at £1,560 million.
Further information is available atwww.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc published this content on 08 January 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 08 January 2018 16:04:08 UTC.
Original documenthttps://otp.investis.com/clients/uk/assura1/rns/regulatory-story.aspx?cid=405&newsid=964259
Public permalinkhttp://www.publicnow.com/view/E254A7723813F4DFC4F9BF3809F190692B1A1C16
Assura plc is a United Kingdom-based real estate investment trust (REIT). The Company specializes in the development of, investment in and management of a portfolio of primary care, diagnostic and treatment buildings across the United Kingdom. It develops new buildings, invests in existing buildings, manages portfolios, and ultimately, owns them for the long term. It also designs, builds, invests in, and manages GP surgery, primary care, and community healthcare buildings so the NHS has the places and spaces it needs to deliver more services, tests, and treatments in the community. The Company owns and manages a portfolio of about 612 properties. The Companyâs subsidiaries include Assura (SC1) Ltd, BHE (St James) Ltd, Assura PCP UK Ltd, Metro MRI Ltd, Upton Community Health Care Ltd, Cheltenham Family Health Care Centre Ltd, Upton Medical Ltd, Xantaris Investments (XXI) Ltd, Assura Services Ltd, Assura Primary Care Properties Ltd, Assura Trellech Ltd, and others.